Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation.

Otto MW, McHugh RK, Simon NM, Farach FJ, Worthington JJ, Pollack MH.

Behav Res Ther. 2010 Aug;48(8):720-7. doi: 10.1016/j.brat.2010.04.002. Epub 2010 Apr 28.

PMID:
20546699
2.

Cognitive-behavioral therapy for benzodiazepine discontinuation in panic disorder patients.

Otto MW, Pollack MH, Meltzer-Brody S, Rosenbaum JF.

Psychopharmacol Bull. 1992;28(2):123-30. Review.

PMID:
1355299
3.

Medication discontinuation in panic disorder.

Ballenger JC, Pecknold J, Rickels K, Sellers EM.

J Clin Psychiatry. 1993 Oct;54 Suppl:15-21; discussion 22-4. Review.

PMID:
8262887
4.
5.

Psychosocial interventions for benzodiazepine harmful use, abuse or dependence.

Darker CD, Sweeney BP, Barry JM, Farrell MF, Donnelly-Swift E.

Cochrane Database Syst Rev. 2015;(5):CD009652. Review.

PMID:
26106751
6.

Internal cue exposure and the treatment of substance use disorders: lessons from the treatment of panic disorder.

Otto MW, Safren SA, Pollack MH.

J Anxiety Disord. 2004;18(1):69-87. Review.

PMID:
14725869
7.

Combined pharmacotherapy and cognitive behavior therapy in the treatment of panic disorder.

Gelder MG.

J Clin Psychopharmacol. 1998 Dec;18(6 Suppl 2):2S-5S. Review.

PMID:
9872706
8.
9.

Psychological strategies for discontinuing benzodiazepine treatment.

Spiegel DA.

J Clin Psychopharmacol. 1999 Dec;19(6 Suppl 2):17S-22S. Review.

PMID:
10587280
10.

Medication discontinuation in panic disorder.

Ballenger JC.

J Clin Psychiatry. 1992 Mar;53 Suppl:26-31. Review.

PMID:
1548252
11.

Use of benzodiazepines in panic disorder.

Davidson JR.

J Clin Psychiatry. 1997;58 Suppl 2:26-8; discussion 29-31. Review.

12.

Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.

Herman JB, Brotman AW, Rosenbaum JF.

J Clin Psychiatry. 1987 Oct;48 Suppl:22-8. Review.

PMID:
2889722
13.

Withdrawing benzodiazepines in primary care.

Lader M, Tylee A, Donoghue J.

CNS Drugs. 2009;23(1):19-34. doi: 10.2165/0023210-200923010-00002. Review.

PMID:
19062773
14.

Continuation treatment of panic disorder with high-potency benzodiazepines.

Davidson JR.

J Clin Psychiatry. 1990 Dec;51 Suppl A:31-7. Review.

PMID:
2258375
15.

Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.

Chouinard G.

J Clin Psychiatry. 2004;65 Suppl 5:7-12. Review.

16.

Efficacy studies of alprazolam in panic disorder.

Spiegel DA.

Psychopharmacol Bull. 1998;34(2):191-5. Review.

PMID:
9640999
17.
18.

Drug treatment of panic disorder.

Rosenberg R.

Pharmacol Toxicol. 1993 Jun;72(6):344-53. Review.

PMID:
8103214
19.

Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders.

Burrows GD, Norman TR, Judd FK, Marriott PF.

J Psychiatr Res. 1990;24 Suppl 2:65-72. Review.

PMID:
1980701
20.

Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.

Pompoli A, Furukawa TA, Imai H, Tajika A, Efthimiou O, Salanti G.

Cochrane Database Syst Rev. 2016 Apr 13;4:CD011004. doi: 10.1002/14651858.CD011004.pub2. Review.

PMID:
27071857

Supplemental Content

Support Center